Potential H1-Antihistaminic Drugs: Synthesis of 4-[(2,3-Dihydro-2-oxo-1H-benzimidazol-1-yl)alkoxycarbonyl]-1-(diphenylmethyl)piperazines by Selective Monoalkoxycarbonylation of α,ω-Dichloroalkanes by Phase-Transfer Catalysis
- 13 June 1989
- journal article
- research article
- Published by Wiley in European Journal of Organic Chemistry
- Vol. 1989 (6) , 539-544
- https://doi.org/10.1002/jlac.198919890195
Abstract
No abstract availableKeywords
This publication has 3 references indexed in Scilit:
- Oxatomide, a new orally active drug which inhibits both the release and the effects of allergic mediatorsCellular and Molecular Life Sciences, 1977
- DOUBLE‐BLIND PLACEBO‐CONTROLLED CLINICAL EVALUATION OF OXATIMIDE (R 35443). A NOVEL POTENT ANTI‐ALLERGIC DRUG IN THE TREATMENT OF HAY FEVERAllergy, 1977
- Histamine Antagonists. II.1 Unsymmetrical 1,4-Disubstituted PiperazinesJournal of the American Chemical Society, 1949